The first evidence of the involvement of Tregs in pathogenesis of atherosclerosis was obtained in 2006, when it was demonstrated that ApoE−/− mice depleted with Tregs developed larger and more vulnerable atherosclerotic lesions [50]. Here, APOE is linked to atherosclerosis.